TEVA PHARMACEUTICAL INDUSTRIES LIMITED Effective Income Tax Rate Reconciliation, Tax Contingency, Amount
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Amount of -$1.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxContingencies · last filed 2026-02-03
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED effective income tax rate reconciliation, tax contingency, amount for fiscal 2024 was -$1.00M, a 104.35% decline from fiscal 2023.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED effective income tax rate reconciliation, tax contingency, amount for fiscal 2023 was $23.00M, a 1050.00% increase from fiscal 2022.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED effective income tax rate reconciliation, tax contingency, amount for fiscal 2022 was $2.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED effective income tax rate reconciliation, tax contingency, amount for fiscal 2021 was -$65.00M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 12 month |
|---|---|
| 2024-12-31 | -$1.00M 10-K · filed 2026-02-03 |
| 2023-12-31 | $23.00M 10-K · filed 2026-02-03 |
| 2022-12-31 | $2.00M 10-K · filed 2025-02-05 |
| 2021-12-31 | -$65.00M 10-K · filed 2024-02-12 |
| 2020-12-31 | -$341.00M 10-K · filed 2023-02-10 |
| 2019-12-31 | $172.00M 10-K · filed 2022-02-09 |
| 2018-12-31 | $58.00M 10-K · filed 2021-02-10 |
| 2017-12-31 | -$25.00M 10-K · filed 2020-02-21 |
| 2016-12-31 | -$19.00M 10-K · filed 2019-02-19 |
| 2015-12-31 | -$99.00M 10-K · filed 2018-02-12 |
| 2014-12-31 | $63.00M 20-F · filed 2017-02-15 |
| 2013-12-31 | $206.00M 20-F · filed 2016-02-11 |
| 2012-12-31 | $11.00M 20-F · filed 2015-02-09 |
| 2011-12-31 | $62.00M 20-F · filed 2014-02-10 |